This episode examines the FDA clearance landscape for pharmacological presbyopia interventions, including dual-agent formulations and multifocal toric contact lens platforms. It then analyzes clinical AI integration frameworks presented at the Southern Council of Optometrists and established by the College of American Pathologists, focusing on workflow analysis methods, staff training protocols, and deployment economics within current reimbursement structures. The briefing concludes with regulatory progression for diagnostic software platforms and market consolidation activity that centralizes operational infrastructure through acquisitions and organizational mergers.
